What changed from existing technology?
This study looked at how different amounts of remaining eye focusing power after cataract surgery affect vision with a special lens that helps with near, middle, and far vision.
This study is the first to specifically analyze how different residual spherical equivalents affect visual outcomes with trifocal intraocular lenses across various refractive states.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 1
outcomes of trifocal intraocular lens implantation in patients with cataracts across different refractive states. We aimed to compare the visual outcomes ass
Title ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This research could help ophthalmologists better understand how to optimize trifocal intraocular lens outcomes based on a patient's residual refractive error.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.